PID
Invesco International Dividend Achievers ETF · NAS
- Category Equity
- Expense Ratio 0.53%
- Listing Date Sep 15, 2005
- Volume 69,103.0
- Market Cap (AUM) $897.5M
Performance
+1.66%
1W
+0.41%
1M
+2.45%
3M
+10.39%
6M
+0.29%
YTD
+3.58%
1Y
Top Holdings
-
Name
Symbol%Assets
- Atlantica Sustainable Infrastructure plcAY4.76%
- Brookfield Renewable Partners LPBEP.UT4.39%
- Enbridge Inc.ENB4.22%
- PLDT, Inc. Sponsored ADRPHI4.08%
- British American Tobacco PLC Sponsored ADRBTI3.98%
- Canadian Imperial Bank of CommerceCM3.95%
- Brookfield Infrastructure Partners L.P.BIP3.91%
- National Grid plc Sponsored ADRNGG3.86%
- TELUS CorporationT3.74%
- TC Energy CorporationTRP3.67%
Technical Analysis of PID 2024-05-03
Overview:
In analyzing the technical indicators for PID stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential i...
Recent News & Updates
- 2021-08-11 06:41
BAM Option Traders Banking on Earnings Rise(Investopedia)
- 2020-02-07 01:30
Is Recession Knocking at the Door? ETF Strategies to Follow(Yahoo Finance)
- 2020-01-20 19:33
Economic Slowdown in 2020? ETF Strategies to Help You(Yahoo Finance)
- 2019-08-15 20:00
5 High-Dividend ETFs Available Under $20(Yahoo Finance)
- 2019-04-15 20:00
4 ETF Strategies to Follow Amid Global Growth Slowdown(Yahoo Finance)
- 2018-03-05 22:03
- 2018-02-05 19:10
Dividend plays on slippery ground as bond yields steepen(Yahoo Finance)
- 2018-01-25 18:30
How Is Novartiss Subsidiary Sandoz Positioned for 2018?(Marketrealist)
- 2018-01-21 22:30
Behind Novartiss 4Q17 Estimates: Innovative Medicines(Marketrealist)
- 2017-11-14 00:05
Behind Sanofis 3Q17 Revenue Growth(Marketrealist)
- 2017-09-13 21:19
- 2017-09-13 21:07
How TEVAs CNS Drugs Performed in 1H17(Marketrealist)
- 2017-09-13 01:27
5 Hot Global Dividend ETFs(Yahoo Finance)
- 2017-09-12 22:37
- 2017-09-11 00:32
How ONEOK Has Managed Its Impressive Dividend Yield(Marketrealist)
- 2017-08-30 06:06
- 2017-08-30 02:11
Global Dividend Payments Upbeat in Q2: ETFs to Benefit(Yahoo Finance)
- 2017-08-23 00:42
Dividend Yield of Stanley Black & Decker(Marketrealist)
- 2017-08-17 22:37
A Look at Sanofi Pasteurs Performance in 2Q17(Marketrealist)
- 2017-08-17 19:37
- 2017-08-16 21:07
Sanofi Genzyme Continues Driving Revenue Growth in 2Q17(Marketrealist)
- 2017-08-15 21:32
Kimberly-Clarks Dividend Growth(Marketrealist)
- 2017-07-24 19:39
Novartis in 2Q17: Performance of Sandoz(Marketrealist)
- 2017-07-17 00:05
Analysts Expect Novartiss Revenues to Fall in 2Q17(Marketrealist)
- 2017-06-12 22:36
What Makes This Global Dividend Income ETF So Popular(Yahoo Finance)
- 2017-05-31 21:09
Inside Novartiss Segment-Wise Performance in 1Q17(Marketrealist)
- 2017-05-28 21:06
- 2017-05-02 00:00
Don't Sell, Buy 4 High Dividend ETFs Under $20 in May(Yahoo Finance)
- 2017-05-01 21:07
How GlaxoSmithKlines Vaccines Business Performed in 1Q17(Marketrealist)
- 2017-04-30 19:40
How GlaxoSmithKlines Business Segments Performed in 1Q17(Marketrealist)
- 2017-04-27 05:05
Novartiss 1Q17 Earnings: Innovative Medicines Segment(Marketrealist)
- 2017-04-25 19:36
GlaxoSmithKlines 1Q17 Estimates: Vaccines Business(Marketrealist)
- 2017-04-23 22:37
Analyst Ratings and Recommendations for Novartis(Marketrealist)
- 2017-04-21 01:13
Analyst Estimates for Novartiss 1Q17 Earnings(Marketrealist)
- 2017-04-03 19:36
- 2017-04-02 19:37
Sanofi Genzyme Continued Growth in 2016(Marketrealist)
- 2017-03-29 22:36
Reduced Co-pays May Boost Demand for Entresto(Marketrealist)
- 2017-03-29 19:36
Performance of GlaxoSmithKlines Vaccines Business in 2016(Marketrealist)
- 2017-03-28 19:37
GlaxoSmithKlines Pharmaceuticals Segment Performance(Marketrealist)
- 2017-03-28 02:56
Page 1 of 3
previousnext